Accès ouvert
2026
article
OpenAlex
Alexandra M. Preisser, Christian Eisenhawer, Luminița I. Cerviș, Andreas Deimling et autres
This manuscript is a translation of the corresponding German Guideline "S2k-Leitlinie Diagnostik und Begutachtung der Berufskrankheit Nr. 4101 Quarzstaublungenerkrankung (Silikose) der Berufskrankheitenverordnung (BKV)." The guideline provides a structured framework for the expert assessment of quartz dust-related lung disease (Occupational Disease No. 4101, …
de, si
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Alexandra M. Preisser, Christian Eisenhawer, Luminița I. Cerviş, Andreas Deimling et autres
This manuscript is a translation of the corresponding German Guideline “S2k-Leitlinie Diagnostik und Begutachtung der Berufskrankheit Nr. 4101 Quarzstaublungenerkrankung (Silikose) der Berufskrankheitenverordnung (BKV).” The guideline provides a structured framework for the expert assessment of quartz dust-related lung disease (Occupational Disease No. 4101, …
de, si
(code pays fourni par la source)
2025
erratum
OpenAlex
Alexandra M. Preisser, Christian Eisenhawer, Luminiţa I. Cerviș, Andreas von Deimling et autres
Correction to: S2k-Leitlinie: Diagnostik und Begutachtung der Berufskrankheit Nr. 4101 Quarzstaublungenerkrankung (Silikose) der Berufskrankheitenverordnung (BKV) Pneumologie eFirst DOI: 10.1055/a-2594-6457 Erratum Preisser AM, Eisenhawer C, Cerviș LI et al. S2k-Leitlinie: Diagnostik und Begutachtung der Berufskrankheit Nr. 4101 Quarzstaublungenerkrankung (Silikose) der Berufskrankheitenverordnung (BKV). Pneumologie …
de
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Alexandra M. Preisser, Christian Eisenhawer, Luminiţa I. Cerviș, Andreas von Deimling et autres
The current revision of the guideline incorporates scientific evidence published since 2016, as well as insights gained from its application in clinical and medico-legal practice. It is specifically intended for medical experts involved in the assessment of quartz dust-induced pneumoconiosis as occupational …
de
(code pays fourni par la source)
2025
book-chapter
OpenAlex
Inke Sabine Feder, A. Theile, Andrea Tannapfel
de
(code pays fourni par la source)
2025
erratum
OpenAlex
Alexandra M. Preisser, Christian Eisenhawer, Kathrin Ludwig, Dennis Nowak et autres
Preisser, Alexandra M; Eisenhawer, Christian; Cerviș, Luminiţa I; Deimling, Andreas; Duell, Melanie; Feder, Inke S; Heise, Bernhard; Hofmann-Preiß, Karina; Jonigk, Danny; Kraus, Thomas; Ludwig, Kathrin; Nowak, Dennis; Tannapfel, Andrea; Zagrodnik, Fred-Dieter; Worth, Heinrich
Accès ouvert
2024
article
OpenAlex
Ira Ekmekçiu, Doreen Maria Zucha, Jens Christmann, Sarah Wisser et autres
Introduction: Understanding the mutational landscape of colon cancer (CC) is crucial for targeted therapy development. Microsatellite instability (MSI-H), rat sarcoma (RAS), and B-Raf proto-oncogene, serine/threonine kinase (BRAF) mutations (MT) are pivotal markers. Further investigation into clinicopathological features of RAS and BRAF MT …
de
(code pays fourni par la source)
2024
article
OpenAlex
Inke Sabine Feder, Enrico Fruth, Andrea Tannapfel
de
(code pays fourni par la source)
Accès ouvert
2023
article
OpenAlex
Doreen Maria Gisder, Iris Tischoff, Jens Christmann, Inke Sabine Feder et autres
de
(code pays fourni par la source)
2023
article
OpenAlex
Doreen Maria Gisder, Jens Christmann, Sarah Wisser, Berlinda Verdoodt et autres
Background The comprehensive analysis of the mutational status of colon cancer (CC) may identify targetable alterations also in early stages. Analyzing real life data may show the potential for beneficial treatment choices, e.g. immunotherapy in microsatellite instable (MSI) tumors. So far, there …
de
(code pays fourni par la source)
2023
conference-abstract
OpenAlex
Doreen Maria Gisder, Sarah Wisser, Céline Lugnier, Jens Christmann et autres
e15535 Background: The comprehensive analysis of the mutational status of colon cancer (CC) may identify targetable alterations also in early stages. This may open up potential beneficial treatment choices, e.g. immunotherapy in microsatellite instable (MSI) tumors. So far, there is few data …
de
(code pays fourni par la source)
Accès ouvert
2023
other
OpenAlex
Martin Filipits, Margaretha Rudas, R. Jakesz, Peter Dubsky et autres
Abstract Purpose: According to current guidelines, molecular tests predicting the outcome of breast cancer patients can be used to assist in making treatment decisions after consideration of conventional markers. We developed and validated a gene expression signature predicting the likelihood of distant …
at, de
(code pays fourni par la source)